Research progress of the role of phospholysine phosphohistidine inorganic pyrophosphate phosphatase in tumor
TANG Xiang1 WANG Jingzhi2 LIU Na1 CHEN Deyu1#br#
1.Department of Oncology, Affiliated Hospital of Jiangsu University, Jiangsu Province, Zhenjiang 212001, China;
2.Department of Radiotherapy, Yancheng First People’s Hospital, Jiangsu Province, Yancheng 224001, China
Abstract Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) is one of the important enzyme regulating histidine dephosphorylation, mainly expressed in liver, brain and kidney, and the regulation of histidine residues together with histidine kinase phosphorylation and dephosphorylation. The deletion of LHPP can destroy the balance between phosphorylation and dephosphorylation of histidine residues, resulting in PI3K/Akt and Wnt/β-catenin which, leads to the abnormality of cyclin and apoptotic protein, and promotes the occurrence and development of tumor. LHPP is significant for early screening, early diagnosis, treatment and prognosis of tumor patients, and it is expected to become a new therapeutic target and prognostic index for individualized treatment of patients. Based on the previous literature research, this review summarizes the research progress of the role of LHPP in some tumors such as liver cancer, glioma, and kidney cancer, in order to provide reference for the future research direction and application of LHPP in tumors.
TANG Xiang1 WANG Jingzhi2 LIU Na1 CHEN Deyu1. Research progress of the role of phospholysine phosphohistidine inorganic pyrophosphate phosphatase in tumor[J]. 中国医药导报, 2022, 19(19): 34-40.
[1] Li Y，Yang D，Tian N，et al. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation [J]. J Biol Chem，2019，294（40）：14745-14756.
[2] Wellen K，Hatzivassiliou G，Sachdeva U，et al. ATP-citrate lyase links cellular metabolism to histone acetylation [J]. Sci，2009，324（5930）：1076-1080.
[3] Zhang D，Tang Z，Huang H，et al. Metabolic regulation of gene expression by histone lactylation [J]. Nat，2019，574（7779）：575-580.
[4] Hindupur S，Colombi M，Fuhs S，et al. The protein histidine phosphatase LHPP is a tumour suppressor [J]. Nat，2018，555（7698）：678-682.
[5] Ek P，Pettersson G，Ek B，et al. Identification and characterization of a mammalian 14-kDa phosphohistidine phosphatase [J]. Eur J Biochem，2002，269（20）：5016-5023.
[6] Xia R，Yao D，Cai X，et al. LHPP-Mediated Histidine Dephosphorylation Suppresses the Self-Renewal of Mouse Embryonic Stem Cells [J]. Front Cell Dev Biol，2021，9：638815.
[7] Yokoi F，Hiraishi H，Izuhara K. Molecular cloning of a cDNA for the human phospholysine phosphohistidine inorganic pyrophosphate phosphatase [J]. J Biochem，2003， 133（5）：607-614.
[8] Seal U，Binkley F. An inorganic pyrophosphatase of swine brain [J]. J Biol Chem，1957，228（1）：193-199.
[9] Hauser A，Hwang S，Sun H，et al. Combining free energy calculations with tailored enzyme activity assays to elucidate substrate binding of a phospho-lysine phosphatase [J]. Chem Sci，2020，11（47）：12655-12661.
[10] Kee J，Muir T. Chasing phosphohistidine，an elusive sibling in the phosphoamino acid family [J]. ACS Chem Biol，2012，7（1）：44-51.
[11] Hou B，Li W，Xia P，et al. LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway [J]. Cell Death Discov，2021，7（1）：273.
[12] Ma Y，He S，Gao A，et al. Methylation silencing of TGF-β receptor type Ⅱ is involved in malignant transformation of esophageal squamous cell carcinoma [J]. Clin Epigenetics，2020，12（1）：25.
[13] Boscher C，Joly F，Clarisse B，et al. Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors [J]. Clin Epigenetics，2020，12（10）：3000.
[14] Hong A，Piva M，Liu S，et al. Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity [J]. Cancer Discov，2021，11（3）：714-735.
[15] Xiao J，Gong L，Xiao M，et al. via LINC00467 Promotes Tumor Progression Regulation of the NF-κb Signal Axis in Bladder Cancer [J]. Front Oncol，2021，11：652206.
[16] Srivastava S，Zhdanova O，Di L，et al. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1 [J]. Proc Natl Acad Sci USA，2008，105：14442-14446.
[17] Hou B，Li W，Li J，et al. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the P13K/AKT pathway [J]. Oncol Rep，2020，43（2）：536-548.
[18] Wu F，Chen Y，Zhu J. LHPP suppresses proliferation，migration，and invasion and promotes apoptosis in pancreatic cancer [J]. Biosci Rep，2020，40（3）：BSR20194142.
[19] Li Z，Zhou X，Zhu H，et al. Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT-116 [J]. J Biochem Mol Toxicol，2021，35（3）：e22665.
[20] Li Y，Zhang X，Zhou X，et al. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway [J]. Biosci Rep，2019，39（7）：BSR20182270.
[21] Zhang Q，Xiong M，Liu J，et al. Targeted nanoparticle-mediated LHPP for melanoma treatment [J]. Int J Nanomedicine，2019，14：3455-3468.
[22] Yang X，Meng L，Zhong Y，et al. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis [J]. Aging，2021，13（2）：2864-2884.
[23] Sun W，Qian K，Guo K，et al. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway [J]. Acta Biochim Biophys Sin，2020，52（4）：382-389.
[24] Lesseur C，Diergaarde B，Olshan AF，et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer [J]. Nat Genet，2016， 48（12）：1544-1550.
[25] Zheng J，Dai X，Chen H，et al. Down-regulation of LHPP in cervical cancer influences cell proliferation，metastasis and apoptosis by modulating AKT [J]. Biochem Biophys Res Commun，2018，503（2）：1108-1114.
[26] Wu M，Fu T，Chen J，et al. LncRNA GOLGA2P10 is induced by PERK/ATF4/CHOP signaling and protects tumor cells from ER stress-induced apoptosis by regulating Bcl-2 family members [J]. Cell Death Dis，2020，11（4）：276.
[27] Chu P，Tung S，Tsai，K，et al. Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma [J]. Cancers （Basel），2020， 12（7）：32650537.
[28] Liao L，Duan D，Liu Y，et al. LHPP inhibits hepatocellular carcinoma cell growth and metastasis [J]. Cell cycle （Georgetown，Tex），2020，19（14）：1846-1854.
[29] Chen W，Chen L，Wang J，et al. LHPP impedes energy metabolism by inducing ubiquitin-mediated degradation of PKM2 in glioblastoma [J]. Am J Cancer Res，2021，11（4）：1369-1390.
[30] Tian Z，Yu T，Wei H，et al. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-Ⅱ in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma [J]. J Clin Lab Anal，2020，34（2）：e23071.
[31] Yan J，He L，Li G，et al. Clinical Value of Serum LHPP-associated miR-765 in the Prognosis of Laparoscopic or Open Hepatectomy for Hepatocellular Carcinoma [J]. Surg Laparosc Endosc Percutan Tech，2020，30（5）：395-402.
[32] Gong H，Fan Z，Yi D，et al. Histidine kinase NME1 and NME2 are involved in TGF-β1-induced HSC activation and CCl-induced liver fibrosis [J]. J Mol Histol，2020，51（5）：573-581.
[33] Kong Y，Feng Z，Zhang Y，et al. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis [J]. Front Immunol，2020，11：1281.
[34] Yang M，Guo W，Yang C，et al. Mobile phone use and glioma risk：A systematic review and meta-analysis [J]. PloS one，2017，12（5）：e0175136.
[35] Gore S，Chougule T，Jagtap J，et al. A Review of Radiomics and Deep Predictive Modeling in Glioma Characterization [J]. Acad Radiol，2020，28（11）：1599-1621.
[36] Li C，Yang J，Wang W，et al. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling [J]. J Bioenerg Biomembr，2021，53（1）：61-71.
[37] Dayton TL，Jacks T，Vander Heiden MG. PKM2，cancer metabolism，and the road ahead [J]. EMBO Rep，2016， 17：1721-1730.
[38] Gui DY，Lewis CA，Vander Heiden MG. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states [J]. Sci Signal，2013，6（263）：pe7.
[39] Faubert B，Solmonson A，DeBerardinis RJ. Metabolic reprogramming and cancer progression [J]. Science，2020，368（6487）：eaaw5473.
[40] Liao L，Liu Z，Langbein L，et al. Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer [J]. Elife，2018，7：e37925.
[41] Naito S，Narisawa T，Kato T，et al. Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma [J]. Int J Urol，2021，28（4）：450-456.
[42] Liou Y，Hsieh Y，Hung T，et al. Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K/Src signaling [J]. Int J Med Sci，2019，16（5）：686-695.
[43] Zhang X，Kang H，Xiao J，et al. LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma[J]. Biomed Res Int [J]. 2020，2020：7020924.
[44] Meng K，Li Z，Cui X. Three LHPP gene-targeting co-expressed microRNAs （microRNA-765，microRNA-21，and microRNA-144） promote proliferation，epithelial-mesenchymal transition，invasion，and are independent prognostic biomarkers in renal cell carcinomas patients [J]. J Clin Lab Anal，2021，35（12）：e24077.
[45] Ye S，Sun B，Wu W，et al. LINC01123 facilitates proliferation，invasion and chemoresistance of colon cancer cells [J]. Biosci Rep，2020，40（8）：BSR20194062.
[46] Wang Y，Dong X，Qu Z，et al. Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer [J]. BMC Cancer，2020，20（1）：900.
[47] Chen R，Sheng L，Zhang J，et al. miR15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer [J]. J Cell Mol Med，2018，22（3）：1855-1863.
[48] Lin Q，Cai J，Wang Q. The Significance of Circular RNA DDX17 in Prostate Cancer [J]. Biomed Res Int，2020， 2020：1878431.
[49] Li J，Xie H，Ying Y，et al. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer [J]. Mol Cancer，2020，19（1）：152.
[50] Yuan L，Yu L，Zhang J，et al. Long non coding RNA H19 protects H9c2 cells against hypoxia induced injury by activating the PI3K/AKT and ERK/p38 pathways [J]. Mol Med Rep，2020，21（4）：1709-1716.
[51] Sahin I，Christodoulou M，Guzelcan E，et al. A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition [J]. Sci Rep，2020，10（1）：11814.
[52] Pothongsrisit S，Pongrakhananon V. Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer： An Update Regarding Potential Drugs and Natural Products [J]. Molecules，2021，26（13）：4100-4126
